Evidence map›Paper›PMID 41272551›Full record

ArticleBMC infectious diseases2025

Pandemic shadows in the operating room how COVID-19 altered the risk and timing of surgical site infections: a multivariable risk assessment and time-to-event analysis in a cohort of abdominal surgery patients.

Fatimah Alshahrani, Ibraheem Altamimi, Ahmed Alhawamdeh, Sultan Alshehri, Mohamed Yaser Alquhidan, Saud Alhasani, Badr Alshehri, Mohammed Alshehri, Bassam Tarig Alkhuwaitir, Mohammed N Alhuqbani and 7 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Fatimah AlshahraniCollege of Medicine, King Saud Universty, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-4646-7488
Ibraheem AltamimiCollege of Medicine, King Saud Universty, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-5149-0877
Ahmed AlhawamdehCollege of Medicine, King Saud Universty, Riyadh, Saudi Arabia.ORCID https://orcid.org/0009-0005-6030-5767
Sultan AlshehriCollege of Medicine, King Saud Universty, Riyadh, Saudi Arabia.ORCID https://orcid.org/0009-0006-8888-8842
Mohamed Yaser AlquhidanCollege of Medicine, King Saud Universty, Riyadh, Saudi Arabia.ORCID https://orcid.org/0009-0001-5153-2176
Saud AlhasaniCollege of Medicine, King Saud Universty, Riyadh, Saudi Arabia.ORCID https://orcid.org/0009-0006-7028-6384
Badr AlshehriKing Khalid University Hospital, King Saud University Medical City, Addiriyyah, Riyadh, 12372, Saudi Arabia.ORCID https://orcid.org/0009-0006-7647-3893
Mohammed AlshehriCollege of Medicine, King Saud Universty, Riyadh, Saudi Arabia.ORCID https://orcid.org/0009-0004-4955-0625
Bassam Tarig AlkhuwaitirKing Khalid University Hospital, King Saud University Medical City, Addiriyyah, Riyadh, 12372, Saudi Arabia.ORCID https://orcid.org/0009-0009-4282-3447
Mohammed N AlhuqbaniDepartment of Orthopedic Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Samah Mustafa AdamDepartment of Infection Prevention and Control, King Saud University Medical City, Riyadh, Saudi Arabia.
Rasha Assad AssiriDepartment of Basic Medical Sciences, College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, 11671, Saudi Arabia.ORCID https://orcid.org/0000-0001-8946-4618
Hamad Ali AlyamiDepartment of Adult Infectious Diseases, King Saud Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0009-0007-3320-4391
Nada Abdullah AlharbiDepartment of Basic Medical Sciences, College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, 11671, Saudi Arabia.ORCID https://orcid.org/0000-0003-4674-4921
Thamir Saad AlsaeedDepartment of Biology and Immunology, College of Medicine, Qassim University, Qassim, Saudi Arabia.ORCID https://orcid.org/0000-0003-0936-281X
Ali A RabaanMolecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, 31311, Saudi Arabia.ORCID https://orcid.org/0000-0002-6774-9847
Abba Amsami ElgujjaDepartment of Infection Prevention and Control, King Saud University Medical City, Riyadh, Saudi Arabia. elgujja@yahoo.com.ORCID https://orcid.org/0000-0003-0476-8810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurgical site infections (SSIs) are among the most frequent and preventable complications following abdominal surgery, influenced by patient, procedural, and systemic factors. The coronavirus disease 2019 (COVID-19) pandemic introduced new perioperative protocols-including universal masking, visitor restrictions, enhanced personal protective equipment (PPE) use, and modified operating-room workflows-that may have altered infection dynamics. This retrospective cohort study, conducted in a large tertiary center in Saudi Arabia, examined whether these changes affected SSI risk and timing using survival analysis.

objectivesTo determine SSI incidence, identify independent risk factors, and assess how the COVID-19 pandemic influenced infection onset and outcomes among patients undergoing abdominal surgery.

methodsWe reviewed 809 adult abdominal-surgery cases between January 2019 and December 2022. Data were extracted from the hospital's electronic health-record system by two independent reviewers using a standardized form under institutional approval (IRB No. E-22-6926). Data confidentiality was strictly maintained. SSIs were defined according to the U.S. Centers for Disease Control and Prevention (CDC) criteria. Multivariable logistic regression identified independent predictors, while Kaplan-Meier and Cox regression analyses evaluated infection-free survival and time-to-event outcomes.

resultsOf 809 patients, 47 (5.8%) developed SSIs, a rate consistent with international benchmarks. Independent predictors included diabetes mellitus (adjusted odds ratio [OR] 2.14; 95% CI 1.05-4.34), contaminated wounds (OR 3.67; 95% CI 1.58-8.54), and postoperative hyperglycemia ≥ 7 mmol/L (OR 2.95; 95% CI 1.32-6.57). During the pandemic, infections occurred later in the postoperative course, suggesting a delayed onset despite similar median times to infection. No multicollinearity was observed, and model diagnostics confirmed stability.

conclusionSSIs remain a significant postoperative concern. Diabetes, wound contamination, and hyperglycemia were consistent predictors. Pandemic-related procedural adaptations may have delayed infection onset, underscoring the need for extended postoperative surveillance and context-specific infection-control strategies during public-health emergencies.

Indexed as

AbdomenCOVID-19Operating RoomsSurgical Wound InfectionAdultAgedFemaleHumansIncidenceInfection ControlMaleMiddle AgedPandemicsPersonal Protective EquipmentRetrospective StudiesRisk AssessmentAbdominal surgeryCOVID-19Cox regressionHyperglycemiaInfection controlPostoperative complicationsRisk factorsSurgical site infectionSurvival analysisWound classification

Identifiers

PMID41272551
PMCPMC12750568

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.